Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burgess

Showing results (1-10 of 420) with videos related to

Pageof 42
Sort By:
Kidney International. Supplement|June 16, 1999
Management of focal segmental glomerulosclerosis: evidence-based recommendationsE Burgess
Blood Pressure. Supplement|May 3, 2001
Renal effects of angiotensin II receptor antagonistsE Burgess
British Journal of Clinical Pharmacology|November 1, 1991
Aluminum absorption following sucralfate therapyE Burgess
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Intraperitoneal cefoperazone treatment resulting in coagulation abnormalityE Burgess
Nursing Times|April 20, 2002
Find the time to visit EarthE Burgess
Pharmacotherapy|January 1, 1992
Prolonged hemodialysis in methanol intoxicationE Burgess
Nephron|January 1, 1991
Aluminum toxicity from oral sucralfate therapyE Burgess
The Canadian Journal of Cardiology|January 1, 1994
Hypertension in the elderlyE Burgess
Kidney International. Supplement|June 16, 1999
Conservative treatment to slow deterioration of renal function: evidence-based recommendationsE Burgess
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|March 9, 1999
The Rose model, revisitedA E Burgess
Pageof 42

Showing results (1-10 of 420) with videos related to

Sort By:
Pageof 42
Kidney International. Supplement|June 16, 1999
Management of focal segmental glomerulosclerosis: evidence-based recommendationsE Burgess
Blood Pressure. Supplement|May 3, 2001
Renal effects of angiotensin II receptor antagonistsE Burgess
British Journal of Clinical Pharmacology|November 1, 1991
Aluminum absorption following sucralfate therapyE Burgess
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Intraperitoneal cefoperazone treatment resulting in coagulation abnormalityE Burgess
Nursing Times|April 20, 2002
Find the time to visit EarthE Burgess
Pharmacotherapy|January 1, 1992
Prolonged hemodialysis in methanol intoxicationE Burgess
Nephron|January 1, 1991
Aluminum toxicity from oral sucralfate therapyE Burgess
The Canadian Journal of Cardiology|January 1, 1994
Hypertension in the elderlyE Burgess
Kidney International. Supplement|June 16, 1999
Conservative treatment to slow deterioration of renal function: evidence-based recommendationsE Burgess
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|March 9, 1999
The Rose model, revisitedA E Burgess
Pageof 42